We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Pfizer Inc | NYSE:PFE | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.54 | 2.13% | 25.93 | 26.00 | 25.35 | 25.39 | 38,372,313 | 01:00:00 |
From Apr 2019 to Apr 2024
By Colin Kellaher
ContraFect Corp. on Tuesday said Pfizer Inc., one of its biggest shareholders, will invest another $3 million through a private placement.
The Yonkers, N.Y., biotechnology company said Pfizer agreed to buy 674,156 common shares and a warrant to buy 505,617 shares in a private placement slated to close on Wednesday.
ContraFect said the transaction is contingent upon the closing of a $52.5 million public offering it announced last week.
Pfizer late last year bought about 11.1 million shares of ContraFect at 27 cents apiece and currently holds a roughly 7.25% stake in the company.
ContraFect said it will use the new funds from Pfizer to continue Phase 3 trial of exebacase in Staph aureus bacteremia.
ContraFect shares rose 1.5% to $5.53 in early trading Tuesday.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
May 26, 2020 10:00 ET (14:00 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year Pfizer Chart |
1 Month Pfizer Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
